Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer

Radiotherapy and Oncology

Volumn 99, Issue 2, 2011, Pages 137-141

  Van Den Bogaard, Jørgen ^a   Janssen, Marco H M ^a,c   Janssens, G ^b   Buijsen, Jeroen ^a   Reniers, Brigitte ^a   Lambin, Philippe ^a   Lammering, Guido ^a   Öllers, Michel C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c MAASTRO CLINIC   (Netherlands)

Author keywords

FDG uptake; Morphons; Non rigid image registration; Rectal cancer; Residual disease

Indexed keywords

CAPECITABINE; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOGRAM; HUMAN; LOCALLY ADVANCED RECTAL CANCER; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECTUM CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79958165992     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.04.004     Document Type: Article

References (34)

1. V. Valentini Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies Int J Radiat Oncol Biol Phys 51 2001 371 383 (Pubitemid 32884284)
2. C. Capirci Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy Eur J Nucl Med Mol Imaging 34 2007 1583 1593 (Pubitemid 47476915)
3. C. Capirci Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy AJR Am J Roentgenol 187 2006 W202 W208
4. M.H. Janssen Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings Radiother Oncol 94 2010 151 155
5. M.H. Janssen Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F- fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 2009 392 399
6. R.F. Vliegen Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 184 2008 457 464
7. H.T. Eich Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer: prognostic significance of tumor regression Strahlenther Onkol 187 2011 225 230
8. M. Maas Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
9. A. van Baardwijk Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
10. S.F. Petit Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study Radiother Oncol 91 2009 393 398
11. Petit SF, et al. [(18)F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients. Int J Radiat Oncol Biol Phys, 2010; doi:10.1016/j.ijrobp.2010.06.016.
12. S.M. Bentzen Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology Cancer Treat Res 139 2008 41 62
13. S.M. Bentzen Theragnostic imaging for radiation oncology: dose-painting by numbers Lancet Oncol 6 2005 112 117 (Pubitemid 40197705)
14. B. Vanderstraeten [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer Radiother Oncol 79 2006 249 258 (Pubitemid 44093755)
15. K. Tanderup, D.R. Olsen, and C. Grau Dose painting: art or science? Radiother Oncol 79 2006 245 248 (Pubitemid 44093758)
16. M. Piert Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside J Nucl Med 46 2005 106 113 (Pubitemid 43086004)
17. S.S. Foo Functional imaging of intratumoral hypoxia Mol Imaging Biol 6 2004 291 305 (Pubitemid 39263636)
18. E.R. Velazquez Prediction of residual metabolic activity after treatment in NSCLC patients Acta Oncol 49 2010 1033 1039
19. H.J. Aerts Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 2008 1402 1407
20. C. Schutze Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice Radiother Oncol 83 2007 311 315 (Pubitemid 46915542)
21. H.J. Aerts Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
22. ICRU report 50. Prescribing, Recording, and Reporting Photon Beam Therapy. 1993.
23. ICRU report 50. Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU 50). ICRU report 62. 1999.
24. Knutsson H, Andersson M, Morphons: segmentation using elastic canvas and paint on priors. Proc IEEE Int Conf Image Process 2005:1226-9. (Pubitemid 44539167)
25. Janssens, G. Diffeomorphic registration of images with variable contrast enhancement. Int J Biomed Imaging, 2011:2011.
26. G. Janssens Evaluation of nonrigid registration models for interfraction dose accumulation in radiotherapy Med Phys 36 2009 4268 4276
27. J.F. Daisne Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother Oncol 69 2003 247 250
28. M. Ollers The integration of PET-CT scans from different hospitals into radiotherapy treatment planning Radiother Oncol 87 2008 142 146
29. P. Lambin The ESTRO Breur lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiother Oncol 96 2010 145 152
30. S.F. Petit Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study Phys Med Biol 54 2009 2179 2196
31. R.G. van Stiphout Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging Radiother Oncol 98 2011 126 133
32. S.M. Larson Cancer or inflammation? A Holy Grail for nuclear medicine J Nucl Med 35 1994 1653 1655
33. P.F. Kao, Y.H. Chou, and C.W. Lai Diffuse FDG uptake in acute prostatitis Clin Nucl Med 33 2008 308 310
34. M.H. Janssen Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F- fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 2010 392 399